» Articles » PMID: 28576498

Characterization of Cancer Stem Cell Drug Resistance in the Human Colorectal Cancer Cell Lines HCT116 and SW480

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2017 Jun 4
PMID 28576498
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer stem cells (CSCs) share a number of properties with somatic stem cells including heightened protective mechanisms and the ability to self-renew. CSCs are a critical subpopulation of cancer cells implicated in tumor formation, metastases and recurrence.

Methods: We used serial colonosphere culture to enrich for CSCs from two human CRC cell lines. The expression of proposed colorectal CSC markers and multi-drug resistance genes were assessed via flow cytometry and RT-qPCR. Drug resistance gene expression and self-renewal ability were also determined following treatment with the chemotherapeutic 5-fluorouracil.

Results: Colonosphere culture successfully enriched for a subpopulation of cells with CSC-related gene expression and heightened self-renewal ability, particularly in the SW480 cell line. Chemotherapy treatment significantly reduced sphere formation however a small fraction of cells survived treatment and retained their self-renewal ability.

Conclusions: Our findings support the use of the sphere formation assay to study CSCs. The ability of cells to self-renew following chemotherapy treatment highlights the importance of targeting both the bulk of tumor cells and the CSC population to prevent recurrence in colorectal cancer.

Citing Articles

Cellular Effects of Selected Unsymmetrical Bisacridines on the Multicellular Tumor Spheroids of HCT116 Colon and A549 Lung Cancer Cells in Comparison to Monolayer Cultures.

Kulesza J, Paluszkiewicz E, Augustin E Int J Mol Sci. 2023; 24(21).

PMID: 37958764 PMC: 10649579. DOI: 10.3390/ijms242115780.


Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity.

Brisset M, Mehlen P, Meurette O, Hollande F Front Cell Dev Biol. 2023; 11:1231416.

PMID: 37860822 PMC: 10582728. DOI: 10.3389/fcell.2023.1231416.


Resveratrol as sensitizer in colorectal cancer plasticity.

Brockmueller A, Sajeev A, Koklesova L, Samuel S, Kubatka P, Busselberg D Cancer Metastasis Rev. 2023; 43(1):55-85.

PMID: 37507626 PMC: 11016130. DOI: 10.1007/s10555-023-10126-x.


Selecting the appropriate indirect viability assay for 3D paper-based cultures: a data-driven study.

Sitte Z, Larson T, McIntosh J, Sinanian M, Lockett M Analyst. 2023; 148(10):2245-2255.

PMID: 37073480 PMC: 10192127. DOI: 10.1039/d3an00283g.


MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis.

Zou Y, Zhong C, Hu Z, Duan S Front Oncol. 2021; 11:743701.

PMID: 34676171 PMC: 8523946. DOI: 10.3389/fonc.2021.743701.